Drug Warning for Strattera in Children with ADHD

cascade falls

The FDA has issued a warning that Strattera, a drug used to treat attention deficit hyperactivity disorder (ADHD), can cause suicidal thinking in some children and adolescents. Manufacturer Eli Lilly & Co. responded by announcing that a “black-box warning” will be added to the drug’s label in the United States. There was no evidence of increased suicidal thinking in adults. Last year, the FDA also ordered that all antidepressants must bear warnings that they “increase the risk of suicidal thinking and behavior” in children who take them.